Clinical Trial Update: Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating a combination of maraviroc and raltegravir in treatment-naive HIV-1 patients is reported as a clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• Selzentry (Maraviroc)

Snippet

Sponsor: Association Pour la Recherche en Infectiologie | Conditions: HIV | Phase 2 | Status: UNKNOWN